Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Computational and Practical Aspects of Drug Repositioning

Assay and Drug Development Technologies
Drug DiscoveryMolecular Medicine
2015English

Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2014English

Additional Neural Matrix Factorization Model for Computational Drug Repositioning

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Discovery and Validation of Breast Cancer Early Detection Biomarkers in Preclinical Samples

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2010English

Sunitinib for Advanced Renal Cell Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2020English

Computational Cell Dosimetry for Cancer Radiotherapy and Diagnostic Radiology

English

Second-Line Treatment for Renal Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Large-Scale Computational Drug Repositioning to Find Treatments for Rare Diseases

npj Systems Biology and Applications
GeneticsMolecular BiologyBiochemistryApplied MathematicsSimulationComputer Science ApplicationsModelingDrug Discovery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy